URINARY TRACT INFECTIONS—Problems in Medical Management

The lesion principally responsible for chronic, or recurrent, urinary tract infection is a focus in the interstitial tissue of the kidney. Most cursory antimicrobial therapy suppresses the manifestations of lower urinary tract involvement but does not eradicate the renal focus. In order to cure rath...

Full description

Saved in:
Bibliographic Details
Published in:California medicine 1953-08, Vol.79 (2), p.99-102
Main Author: JAWETZ, E
Format: Article
Language:English
Subjects:
Chronic Disease
Disease Management
Humans
Kidney
Old Medline
Pyelonephritis - therapy
Renal Insufficiency
Urinary Tract Infections
Urologic Diseases
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 102
container_issue 2
container_start_page 99
container_title California medicine
container_volume 79
creator JAWETZ, E
description The lesion principally responsible for chronic, or recurrent, urinary tract infection is a focus in the interstitial tissue of the kidney. Most cursory antimicrobial therapy suppresses the manifestations of lower urinary tract involvement but does not eradicate the renal focus. In order to cure rather than merely suppress the infection, it is imperative that, as early as possible, steps be taken to isolate and identify the etiologic microorganism and to determine its sensitivity to antimicrobial agents. Based on this information sufficient amounts of drug should be given for an adequate period (probably at least two weeks) to eradicate the infection within the renal tissue. Such a program would tend to reduce the number of cases in which irreversible renal failure develops from chronic pyelonephritis.
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1522012</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3993869341</sourcerecordid><originalsourceid>FETCH-LOGICAL-i245t-650f413b8fc3327d576c914e5def6ea54d6f1e4045f115f8cf4d886e7654e1873</originalsourceid><addsrcrecordid>eNpdkMtKw0AUhgdRbK2-ggQEd4G5z2QjlNBqaJtKTQuuhmkyU1NzqUkquvMhfEKfxEBrUVdn8X985z_nCHQxkdD1POodgy6EULoIc9oBZ3W9hpAKJuUp6CACuYAYd4E3nwVhf_boRLO-HzlBOBz4UTANH74-Pu-rcpmZvHbSwpmYJI115kx0oVcmN0VzDk6szmpzsZ89MB8OIv_OHU9vA78_dlNMWeNyBi1FZCltTAgWCRM89hA1LDGWG81owi0yFFJmEWJWxpYmUnIjOKMGSUF64Gbn3WyXuUnidnWlM7Wp0lxX76rUqfqbFOmTWpWvCjGMIcKt4HovqMqXrakblad1bLJMF6bc1kowLAn3ZAte_QPX5bYq2uMUEoJBKTGELXX5u8-hyM9PW8DdAWndmLdDrqtnxQURTIULX41GkyhEWKoF-QZcsYD-</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1775088200</pqid></control><display><type>article</type><title>URINARY TRACT INFECTIONS—Problems in Medical Management</title><source>PubMed Central (Training)</source><creator>JAWETZ, E</creator><creatorcontrib>JAWETZ, E</creatorcontrib><description>The lesion principally responsible for chronic, or recurrent, urinary tract infection is a focus in the interstitial tissue of the kidney. Most cursory antimicrobial therapy suppresses the manifestations of lower urinary tract involvement but does not eradicate the renal focus. In order to cure rather than merely suppress the infection, it is imperative that, as early as possible, steps be taken to isolate and identify the etiologic microorganism and to determine its sensitivity to antimicrobial agents. Based on this information sufficient amounts of drug should be given for an adequate period (probably at least two weeks) to eradicate the infection within the renal tissue. Such a program would tend to reduce the number of cases in which irreversible renal failure develops from chronic pyelonephritis.</description><identifier>ISSN: 0008-1264</identifier><identifier>EISSN: 2380-9949</identifier><identifier>PMID: 13067022</identifier><language>eng</language><publisher>United States: BMJ Publishing Group LTD</publisher><subject>Chronic Disease ; Disease Management ; Humans ; Kidney ; Old Medline ; Pyelonephritis - therapy ; Renal Insufficiency ; Urinary Tract Infections ; Urologic Diseases</subject><ispartof>California medicine, 1953-08, Vol.79 (2), p.99-102</ispartof><rights>Copyright BMJ Publishing Group LTD Aug 1953</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1522012/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1522012/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/13067022$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>JAWETZ, E</creatorcontrib><title>URINARY TRACT INFECTIONS—Problems in Medical Management</title><title>California medicine</title><addtitle>Calif Med</addtitle><description>The lesion principally responsible for chronic, or recurrent, urinary tract infection is a focus in the interstitial tissue of the kidney. Most cursory antimicrobial therapy suppresses the manifestations of lower urinary tract involvement but does not eradicate the renal focus. In order to cure rather than merely suppress the infection, it is imperative that, as early as possible, steps be taken to isolate and identify the etiologic microorganism and to determine its sensitivity to antimicrobial agents. Based on this information sufficient amounts of drug should be given for an adequate period (probably at least two weeks) to eradicate the infection within the renal tissue. Such a program would tend to reduce the number of cases in which irreversible renal failure develops from chronic pyelonephritis.</description><subject>Chronic Disease</subject><subject>Disease Management</subject><subject>Humans</subject><subject>Kidney</subject><subject>Old Medline</subject><subject>Pyelonephritis - therapy</subject><subject>Renal Insufficiency</subject><subject>Urinary Tract Infections</subject><subject>Urologic Diseases</subject><issn>0008-1264</issn><issn>2380-9949</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1953</creationdate><recordtype>article</recordtype><recordid>eNpdkMtKw0AUhgdRbK2-ggQEd4G5z2QjlNBqaJtKTQuuhmkyU1NzqUkquvMhfEKfxEBrUVdn8X985z_nCHQxkdD1POodgy6EULoIc9oBZ3W9hpAKJuUp6CACuYAYd4E3nwVhf_boRLO-HzlBOBz4UTANH74-Pu-rcpmZvHbSwpmYJI115kx0oVcmN0VzDk6szmpzsZ89MB8OIv_OHU9vA78_dlNMWeNyBi1FZCltTAgWCRM89hA1LDGWG81owi0yFFJmEWJWxpYmUnIjOKMGSUF64Gbn3WyXuUnidnWlM7Wp0lxX76rUqfqbFOmTWpWvCjGMIcKt4HovqMqXrakblad1bLJMF6bc1kowLAn3ZAte_QPX5bYq2uMUEoJBKTGELXX5u8-hyM9PW8DdAWndmLdDrqtnxQURTIULX41GkyhEWKoF-QZcsYD-</recordid><startdate>19530801</startdate><enddate>19530801</enddate><creator>JAWETZ, E</creator><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>MBDVC</scope><scope>PADUT</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19530801</creationdate><title>URINARY TRACT INFECTIONS—Problems in Medical Management</title><author>JAWETZ, E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-i245t-650f413b8fc3327d576c914e5def6ea54d6f1e4045f115f8cf4d886e7654e1873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1953</creationdate><topic>Chronic Disease</topic><topic>Disease Management</topic><topic>Humans</topic><topic>Kidney</topic><topic>Old Medline</topic><topic>Pyelonephritis - therapy</topic><topic>Renal Insufficiency</topic><topic>Urinary Tract Infections</topic><topic>Urologic Diseases</topic><toplevel>online_resources</toplevel><creatorcontrib>JAWETZ, E</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest research library</collection><collection>ProQuest Science Journals</collection><collection>Research Library (Corporate)</collection><collection>Research Library China</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>California medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>JAWETZ, E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>URINARY TRACT INFECTIONS—Problems in Medical Management</atitle><jtitle>California medicine</jtitle><addtitle>Calif Med</addtitle><date>1953-08-01</date><risdate>1953</risdate><volume>79</volume><issue>2</issue><spage>99</spage><epage>102</epage><pages>99-102</pages><issn>0008-1264</issn><eissn>2380-9949</eissn><abstract>The lesion principally responsible for chronic, or recurrent, urinary tract infection is a focus in the interstitial tissue of the kidney. Most cursory antimicrobial therapy suppresses the manifestations of lower urinary tract involvement but does not eradicate the renal focus. In order to cure rather than merely suppress the infection, it is imperative that, as early as possible, steps be taken to isolate and identify the etiologic microorganism and to determine its sensitivity to antimicrobial agents. Based on this information sufficient amounts of drug should be given for an adequate period (probably at least two weeks) to eradicate the infection within the renal tissue. Such a program would tend to reduce the number of cases in which irreversible renal failure develops from chronic pyelonephritis.</abstract><cop>United States</cop><pub>BMJ Publishing Group LTD</pub><pmid>13067022</pmid><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-1264
ispartof California medicine, 1953-08, Vol.79 (2), p.99-102
issn 0008-1264
2380-9949
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1522012
source PubMed Central (Training)
subjects Chronic Disease
Disease Management
Humans
Kidney
Old Medline
Pyelonephritis - therapy
Renal Insufficiency
Urinary Tract Infections
Urologic Diseases
title URINARY TRACT INFECTIONS—Problems in Medical Management
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T07%3A24%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=URINARY%20TRACT%20INFECTIONS%E2%80%94Problems%20in%20Medical%20Management&rft.jtitle=California%20medicine&rft.au=JAWETZ,%20E&rft.date=1953-08-01&rft.volume=79&rft.issue=2&rft.spage=99&rft.epage=102&rft.pages=99-102&rft.issn=0008-1264&rft.eissn=2380-9949&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E3993869341%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-i245t-650f413b8fc3327d576c914e5def6ea54d6f1e4045f115f8cf4d886e7654e1873%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1775088200&rft_id=info:pmid/13067022&rfr_iscdi=true